This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Overlapping Genetic Architecture between Parkinson Disease and Melanoma
- Urinary dysfunction in early and untreated Parkinson's disease
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- Cardiac sympathetic denervation preceding motor signs in Parkinson disease*
- Diagnosis and the premotor phase of Parkinson disease
- The progression of Parkinson disease: A hypothesis
- PET Measurement of Cardiac and Nigrostriatal Denervation in Parkinsonian Syndromes
- Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment
- Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease
- Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson's Disease
- Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure
- Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension
- Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease
- Orthostatic hypotension from sympathetic denervation in Parkinson's disease
- A clinical role for [123I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies
- Cardiac 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease